Want to see IN:DMCC full AI Analyst Report?
Top Page
DMCC Speciality Chemicals Limited
(DMCC)
Select Model
Select Model
Rating:62Neutral
Price Target:
₹269.00
▲(6.79% Upside)
Action:Reiterated
Date:05/20/26
The score is held back primarily by weak FY2026 cash flow (negative operating and free cash flow) despite a reasonably solid balance sheet and recovering revenue/earnings. Support comes from favorable technical momentum (price above major moving averages with positive MACD). Valuation is acceptable but not especially compelling given the low dividend yield.
Positive Factors
Balance-sheet strength
A debt-to-equity near 0.35 and steadily expanding equity provide durable financial flexibility. Manageable leverage limits solvency risk, supports borrowing capacity if needed, and gives the company room to fund investments or weather cyclical dips without immediate refinancing pressure.
Negative Factors
Negative operating and free cash flow
Negative operating and free cash flow in the latest year is a fundamental weakness: earnings are not translating into cash, increasing reliance on external financing for working capital and capex. That elevates funding and execution risk over the medium term if cash trends don't reverse.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet strength
A debt-to-equity near 0.35 and steadily expanding equity provide durable financial flexibility. Manageable leverage limits solvency risk, supports borrowing capacity if needed, and gives the company room to fund investments or weather cyclical dips without immediate refinancing pressure.
Read all positive factors
DMCC Speciality Chemicals Limited (DMCC) vs. iShares MSCI India ETF (INDA)
Market Cap
₹6.34B
Dividend Yield0.97%
Average Volume (3M)2.85K
Price to Earnings (P/E)23.3
Beta (1Y)0.91
Revenue Growth34.84%
EPS Growth26.96%
CountryIN
Employees418
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)11.17
Shares Outstanding24,939,932
10 Day Avg. Volume2,136
30 Day Avg. Volume2,850
Financial Highlights & Ratios
PEG Ratio0.67
Price to Book (P/B)1.98
Price to Sales (P/S)0.85
P/FCF Ratio-14.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DMCC Speciality Chemicals Limited Business Overview & Revenue Model
Company Description
DMCC Speciality Chemicals Limited, alongside its affiliated entities, operates as a manufacturer and global supplier of both specialty and commodity chemicals. Its distribution network spans both domestic Indian markets and international territori...
How the Company Makes Money
null...
DMCC Speciality Chemicals Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
68
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.96B | 5.82B | 4.31B | 3.26B | 3.85B | 3.25B |
| Gross Profit | 1.49B | 935.49M | 1.33B | 1.14B | 1.37B | 1.28B |
| EBITDA | 649.42M | 632.95M | 570.16M | 366.94M | 387.81M | 467.11M |
| Net Income | 278.50M | 273.29M | 215.28M | 115.89M | 69.31M | 213.40M |
Balance Sheet | ||||||
| Total Assets | 3.75B | 4.46B | 3.80B | 3.77B | 4.01B | 3.84B |
| Cash, Cash Equivalents and Short-Term Investments | 27.00M | 44.55M | 51.52M | 70.63M | 33.50M | 29.59M |
| Total Debt | 395.59M | 865.32M | 470.70M | 877.11M | 1.01B | 933.99M |
| Total Liabilities | 1.41B | 1.97B | 1.53B | 1.68B | 2.03B | 1.90B |
| Stockholders Equity | 2.34B | 2.48B | 2.28B | 2.10B | 1.98B | 1.94B |
Cash Flow | ||||||
| Free Cash Flow | 170.43M | -330.45M | 310.28M | 194.33M | 79.75M | -480.71M |
| Operating Cash Flow | 174.18M | -270.57M | 380.41M | 383.74M | 298.81M | 506.56M |
| Investing Cash Flow | -12.05M | -69.76M | -66.82M | -100.42M | -205.59M | -984.14M |
| Financing Cash Flow | -199.02M | 318.06M | -297.83M | -271.01M | -99.94M | 461.07M |
DMCC Speciality Chemicals Limited Technical Analysis
Negative
251.90
Price Trends
271.85
Negative
251.51
Positive
263.02
Negative
Market Momentum
-3.11
Negative
46.57
Neutral
28.09
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DMCC, the sentiment is Negative. The current price of 251.9 is above the 20-day moving average (MA) of 251.57, below the 50-day MA of 271.85, and below the 200-day MA of 263.02, indicating a neutral trend. The MACD of -3.11 indicates Negative momentum. The RSI at 46.57 is Neutral, neither overbought nor oversold. The STOCH value of 28.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DMCC.
DMCC Speciality Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹12.62B | 24.99 | ― | 0.38% | 22.93% | 18.27% | |
71 Outperform | ₹6.81B | 29.20 | ― | ― | 15.71% | -3.48% | |
66 Neutral | ₹2.48B | 19.29 | ― | 1.11% | -39.14% | -65.07% | |
64 Neutral | ₹1.21B | 57.33 | ― | 10.99% | -0.98% | -52.66% | |
62 Neutral | ₹6.34B | 23.33 | ― | 0.97% | 34.84% | 26.96% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
43 Neutral | ₹1.04B | -4.64 | ― | ― | 191.08% | -1160.38% |
* General Sector Average
IN:DMCC
DMCC Speciality Chemicals Limited
254.15
-0.49
-0.19%
IN:CHEMBOND
Chembond Chemicals Limited
184.30
-39.08
-17.50%
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
185.95
-6.77
-3.51%
IN:INDOBORAX
Indo Borax & Chemicals Limited
393.25
173.43
78.90%
IN:OCCL
Oriental Carbon & Chemicals Ltd
121.10
-112.30
-48.11%
IN:REGENCERAM
Regency Ceramics Ltd
39.52
-5.98
-13.14%
DMCC Speciality Chemicals Limited Corporate Events
DMCC Speciality Chemicals Publishes Q4 FY26 Earnings Call Transcript
May 25, 2026
DMCC Speciality Chemicals Limited has released the official transcript of its Q4 FY26 earnings conference call with investors and analysts, held on May 19, 2026, to discuss the company’s financial performance. The document, filed with Indian...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.